html[data-identity='g1'] .g1-header .g1-header-wide .g1-header-layers button { display: none; } html[data-identity='g1'] .g1-header-wide .g1-header-layers a { align-self: center; } html[data-identity='g1'] .g1-header .g1-header-narrow { display: none; } html[data-identity='g1'] .g1-header-nojs { display: none; } @media (width < 721px) { html[data-identity='g1'] .g1-header .g1-header-nojs { display: flex; flex-wrap: wrap; column-gap: 20px; padding: 0 16px 8px; } html[data-identity='g1'] .g1-header-nojs ul { display: flex; gap: 20px; list-style: none; margin: 0; padding: 0; box-shadow: none; } html[data-identity='g1'] .g1-header-nojs a { display: block; padding: 6px 0; font-size: 15px; line-height: 24px; color: var(--ink2); text-decoration: none; } html[data-identity='g1'] .g1-header-nojs a[aria-current='true'] { color: var(--ink); text-decoration: underline 2px var(--ember); text-underline-offset: 6px; } }

Olea europaeaFinding

Olea europaea has no detected effect on HOMA-IR

no difference foundLimited evidenceFinding

01 · The sentence it was drawn from

“There were no effects of OLE intake on fasting glucose, insulin, fructosamine or calculated HOMA-IR or QUICKI indices (Table 6).”

Quoted verbatim from Impact of phenolic-rich olive leaf extract on blood pressure, plasma lipids and inflammatory markers: a randomised controlled trial.

This finding among the 63 findings on its endpoint

Olea europaea

HOMA-IR

no difference found

Who: 60 pre-hypertensive, non-smoking men completing a randomised double-blind crossover (6 weeks each arm, 4-week washout) against a polyphenol-free glycerine and water control
Dose studied: 10 ml twice per day with food (20 ml per day) for 6 weeks

Limited evidencePMID 26951205 · 2017

02 · The study

Study: crossover
Duration: 6 weeks

Evidence, by strength

strong
moderate
limitedthis finding
very limited
insufficient

03 · The paper

European journal of nutrition

Impact of phenolic-rich olive leaf extract on blood pressure, plasma lipids and inflammatory markers: a randomised controlled trial.

2017PMID 26951205doi 10.1007/s00394-016-1188-yIndustry funded

What else it reported2 findings · 0 compounds · 2 endpoints

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M6ZTC2KB48NC2APGE58G6FX3